Yezan Munther Haddadin
CIK 1718004 · last filed 2026-06-03
Yezan Munther Haddadin is a corporate insider who has filed 22 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing shows the insider bought $24.1K of OTLK on Jun 3, 2026. Across all open-market trades the lifetime net is +$143.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $80.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$80.7K
3
22
$143.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OTLK | Director | 66,167 | $1.22 | $80.7K | $104.3K | 11 | 2026-06-03 |
| Outlook Therapeutics, Inc. (OTLKW) Delisted | Director | 30,000 | $0.03 | $900 | $39.3K | 10 | 2021-12-02 |
| Outlook Therapeutics, Inc. (ONSIZ) Delisted | Director | — | — | — | $0 | 1 | 2017-11-02 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | OTLK | Buy (P) | +29,000 | $24.1K | EDGAR |
| 2026-05-27 | OTLK | Buy (P) | +34,000 | $15.0K | EDGAR |
| 2025-10-03 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2024-10-03 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2024-03-29 | OTLK | Buy (P) | +1,881 | $22.2K | EDGAR |
| 2024-03-08 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2023-10-05 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2023-03-31 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2022-10-11 | OTLK | Buy (P) | +33,343 | $42.9K | EDGAR |
| 2022-10-07 | OTLK | Grant (A) | — | $0 | EDGAR |